Associations of Ki-67 Labeling Index with Clinical and Paraclinical Features of Growth Hormone-Secreting Pituitary Adenomas: A Single Center Report from Iran-Reference-Cited by-同舟云学术

Associations of Ki-67 Labeling Index with Clinical and Paraclinical Features of Growth Hormone-Secreting Pituitary Adenomas: A Single Center Report from Iran

Published:2019-04-13 Issue:In Press Volume:In Press Page:
ISSN:1726-913X
Container-title:International Journal of Endocrinology and Metabolism
language:
Short-container-title:Int J Endocrinol Metab

Author:

Mohseni Shahrzad,Aboeerad Maryam,Sharifi Farshad,Tavangar Seyed Mohammad,Mohajeri-Tehrani Mohammadreza

Publisher

Briefland

Subject

Endocrinology, Diabetes and Metabolism

Reference33 articles.

1. Acromegaly

2. Clinical Manifestations and Diagnosis of Acromegaly

3. Multidisciplinary Approach for Acromegaly: A Single Tertiary Center's Experience

4. Resistance to Somatostatin Analogs in Acromegaly

5. Treatment escape reduces the effectiveness of cabergoline during long-term treatment of acromegaly in monotherapy or in association with first-generation somatostatin receptor ligands

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic Characteristics of Somatotroph Pituitary Tumors—An Observational Single-Center Study;Biomedicines;2023-12-15

2. The role of hormonal status, morphological subtypes and proliferative marker Ki-67 labeling index on long-term outcomes in patients with acromegaly: a single tertiary center’s experience;Anatolian Current Medical Journal;2023-10-27

3. Immunohistochemical evaluation of biomarkers with predictive role in acromegaly: a literature review;Romanian Journal of Morphology and Embryology;2023-05-03

4. Preoperative Risk Stratification of Increased MIB-1 Labeling Index in Pituitary Adenoma: A Newly Proposed Prognostic Scoring System;Journal of Clinical Medicine;2022-12-01

5. Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly;Frontiers in Endocrinology;2022-09-16